These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 19897031)

  • 1. An intronic polymorphism of IRF4 gene influences gene transcription in vitro and shows a risk association with childhood acute lymphoblastic leukemia in males.
    Do TN; Ucisik-Akkaya E; Davis CF; Morrison BA; Dorak MT
    Biochim Biophys Acta; 2010 Feb; 1802(2):292-300. PubMed ID: 19897031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter.
    Visser M; Palstra RJ; Kayser M
    Hum Mol Genet; 2015 May; 24(9):2649-61. PubMed ID: 25631878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk.
    Morrison BA; Ucisik-Akkaya E; Flores H; Alaez C; Gorodezky C; Dorak MT
    Autoimmunity; 2010 Dec; 43(8):690-7. PubMed ID: 21067287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia.
    Dorak MT; Lawson T; Machulla HK; Darke C; Mills KI; Burnett AK
    Blood; 1999 Jul; 94(2):694-700. PubMed ID: 10397736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma.
    Gathany AH; Hartge P; Davis S; Cerhan JR; Severson RK; Cozen W; Rothman N; Chanock SJ; Wang SS
    Cancer Causes Control; 2009 Oct; 20(8):1291-302. PubMed ID: 19396635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon regulatory factor 4 regulates thymocyte differentiation by repressing Runx3 expression.
    Cao Y; Li H; Sun Y; Chen X; Liu H; Gao X; Liu X
    Eur J Immunol; 2010 Nov; 40(11):3198-209. PubMed ID: 21061442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of IRF4 aberrant gene expression in the acute leukemias of childhood.
    Adamaki M; Lambrou GI; Athanasiadou A; Tzanoudaki M; Vlahopoulos S; Moschovi M
    PLoS One; 2013; 8(8):e72326. PubMed ID: 23977280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role of interferon regulatory factor 4 (IRF4) in immune cell development.
    Nam S; Lim JS
    Arch Pharm Res; 2016 Nov; 39(11):1548-1555. PubMed ID: 27826752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA complex-linked heat shock protein genes and childhood acute lymphoblastic leukemia susceptibility.
    Ucisik-Akkaya E; Davis CF; Gorodezky C; Alaez C; Dorak MT
    Cell Stress Chaperones; 2010 Sep; 15(5):475-85. PubMed ID: 20012387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia.
    Dorak MT; Owen G; Galbraith I; Henderson N; Webb D; Mills KI; Darke C; Burnett AK
    Leukemia; 1995 May; 9(5):875-8. PubMed ID: 7769851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the Correlation Between Interleukin-6 Promoter Polymorphism -174G/C and Interferon Regulatory Factor 4 rs12203592 Polymorphism With Skin Cancer Susceptibility.
    Wu M; Cao Y; Liu YL; Ma LL; Yang XH
    Am J Ther; 2016; 23(6):e1758-e1767. PubMed ID: 26928068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in IRF4 expression modulates growth characteristics, tyrosinase expression and interferon-gamma response in melanocytic cells.
    Chhabra Y; Yong HXL; Fane ME; Soogrim A; Lim W; Mahiuddin DN; Kim RSQ; Ashcroft M; Beatson SA; Ainger SA; Smit DJ; Jagirdar K; Walker GJ; Sturm RA; Smith AG
    Pigment Cell Melanoma Res; 2018 Jan; 31(1):51-63. PubMed ID: 28755520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4.
    Ma S; Shukla V; Fang L; Gould KA; Joshi SS; Lu R
    J Biol Chem; 2013 Sep; 288(37):26430-40. PubMed ID: 23897826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncogenic transcription factor IRF4 is regulated by a novel CD30/NF-κB positive feedback loop in peripheral T-cell lymphoma.
    Boddicker RL; Kip NS; Xing X; Zeng Y; Yang ZZ; Lee JH; Almada LL; Elsawa SF; Knudson RA; Law ME; Ketterling RP; Cunningham JM; Wu Y; Maurer MJ; O'Byrne MM; Cerhan JR; Slager SL; Link BK; Porcher JC; Grote DM; Jelinek DF; Dogan A; Ansell SM; Fernandez-Zapico ME; Feldman AL
    Blood; 2015 May; 125(20):3118-27. PubMed ID: 25833963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focused screening of a panel of cancer-related genetic polymorphisms reveals new susceptibility loci for pediatric acute lymphoblastic leukemia.
    Offenmüller S; Ravindranath Y; Goyette G; Kanakapalli D; Miller KS; Brecht IB; Zolk O
    Pediatr Blood Cancer; 2014 Aug; 61(8):1411-5. PubMed ID: 24604828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IRF4 rs12203592 functional variant and melanoma survival.
    Potrony M; Rebollo-Morell A; Giménez-Xavier P; Zimmer L; Puig-Butille JA; Tell-Marti G; Sucker A; Badenas C; Carrera C; Malvehy J; Schadendorf D; Puig S
    Int J Cancer; 2017 Apr; 140(8):1845-1849. PubMed ID: 28103633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes.
    Slager SL; Achenbach SJ; Asmann YW; Camp NJ; Rabe KG; Goldin LR; Call TG; Shanafelt TD; Kay NE; Cunningham JM; Wang AH; Weinberg JB; Norman AD; Link BK; Leis JF; Vachon CM; Lanasa MC; Caporaso NE; Novak AJ; Cerhan JR
    Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):461-6. PubMed ID: 23307532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cereblon and IRF4 Variants Affect Risk and Response to Treatment in Multiple Myeloma.
    Butrym A; Łacina P; Rybka J; Chaszczewska-Markowska M; Mazur G; Bogunia-Kubik K
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):151-156. PubMed ID: 28083618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 R72P and MDM2 SNP309 polymorphisms in modification of childhood acute lymphoblastic leukemia susceptibility.
    Do TN; Ucisik-Akkaya E; Davis CF; Morrison BA; Dorak MT
    Cancer Genet Cytogenet; 2009 Nov; 195(1):31-6. PubMed ID: 19837266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.